• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

木犀草素通过抑制PKR激活来保护DYT-细胞免于凋亡。

Luteolin protects DYT- cells from apoptosis by suppressing PKR activation.

作者信息

Frederick Kenneth, Patel Rekha C

机构信息

Department of Biological Sciences, University of South Carolina, Columbia, SC, United States.

出版信息

Front Pharmacol. 2023 Feb 15;14:1118725. doi: 10.3389/fphar.2023.1118725. eCollection 2023.

DOI:10.3389/fphar.2023.1118725
PMID:36874028
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9974672/
Abstract

DYT- is a movement disorder caused by mutations in the gene, which encodes for PACT, the protein activator of interferon-induced, double-stranded RNA (dsRNA)-activated protein kinase PKR. PACT brings about PKR's catalytic activation by a direct binding in response to stress signals and activated PKR phosphorylates the translation initiation factor eIF2α. Phosphorylation of eIF2α is the central regulatory event that is part of the integrated stress response (ISR), an evolutionarily conserved intracellular signaling network essential for adapting to environmental stresses to maintain healthy cells. A dysregulation of either the level or the duration of eIF2α phosphorylation in response to stress signals causes the normally pro-survival ISR to become pro-apoptotic. Our research has established that the mutations reported to cause DYT- lead to enhanced PACT-PKR interactions causing a dysregulation of ISR and an increased sensitivity to apoptosis. We have previously identified luteolin, a plant flavonoid, as an inhibitor of the PACT-PKR interaction using high-throughput screening of chemical libraries. Our results presented in this study indicate that luteolin is markedly effective in disrupting the pathological PACT-PKR interactions to protect DYT- cells against apoptosis, thus suggesting a therapeutic option for using luteolin to treat DYT- and possibly other diseases resulting from enhanced PACT-PKR interactions.

摘要

DYT-是一种由该基因突变引起的运动障碍,该基因编码PACT,即干扰素诱导的双链RNA(dsRNA)激活蛋白激酶PKR的蛋白激活剂。PACT通过响应应激信号直接结合实现PKR的催化激活,而激活的PKR使翻译起始因子eIF2α磷酸化。eIF2α的磷酸化是综合应激反应(ISR)的核心调节事件,ISR是一个进化上保守的细胞内信号网络,对适应环境应激以维持细胞健康至关重要。应激信号响应中eIF2α磷酸化水平或持续时间的失调会导致正常情况下具有促生存作用的ISR转变为促凋亡状态。我们的研究已经证实,据报道导致DYT-的这些突变会增强PACT-PKR相互作用,导致ISR失调并增加对凋亡的敏感性。我们之前通过对化学文库进行高通量筛选,已鉴定出植物黄酮类化合物木犀草素是PACT-PKR相互作用的抑制剂。我们在本研究中展示的结果表明,木犀草素在破坏病理性PACT-PKR相互作用以保护DYT-细胞免受凋亡方面具有显著效果,从而提示木犀草素可作为治疗DYT-以及可能由增强的PACT-PKR相互作用导致的其他疾病的一种治疗选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bc3/9974672/179e19f05933/fphar-14-1118725-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bc3/9974672/d97e02b7e236/fphar-14-1118725-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bc3/9974672/d631296e1a9a/fphar-14-1118725-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bc3/9974672/a280480b4df8/fphar-14-1118725-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bc3/9974672/4746d58505e2/fphar-14-1118725-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bc3/9974672/0121f3b64eb5/fphar-14-1118725-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bc3/9974672/539f1335e731/fphar-14-1118725-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bc3/9974672/d7cde0d4155c/fphar-14-1118725-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bc3/9974672/179e19f05933/fphar-14-1118725-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bc3/9974672/d97e02b7e236/fphar-14-1118725-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bc3/9974672/d631296e1a9a/fphar-14-1118725-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bc3/9974672/a280480b4df8/fphar-14-1118725-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bc3/9974672/4746d58505e2/fphar-14-1118725-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bc3/9974672/0121f3b64eb5/fphar-14-1118725-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bc3/9974672/539f1335e731/fphar-14-1118725-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bc3/9974672/d7cde0d4155c/fphar-14-1118725-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bc3/9974672/179e19f05933/fphar-14-1118725-g008.jpg

相似文献

1
Luteolin protects DYT- cells from apoptosis by suppressing PKR activation.木犀草素通过抑制PKR激活来保护DYT-细胞免于凋亡。
Front Pharmacol. 2023 Feb 15;14:1118725. doi: 10.3389/fphar.2023.1118725. eCollection 2023.
2
Dystonia 16 (DYT16) mutations in PACT cause dysregulated PKR activation and eIF2α signaling leading to a compromised stress response.PACT 中的 Dystonia 16 (DYT16) 突变导致 PKR 激活失调和 eIF2α 信号转导,从而导致应激反应受损。
Neurobiol Dis. 2020 Dec;146:105135. doi: 10.1016/j.nbd.2020.105135. Epub 2020 Oct 10.
3
DYT- Mutation P222L Enhances PACT's Stimulatory Activity on Type I Interferon Induction.DYT-Mutation P222L 增强 PACT 对 I 型干扰素诱导的刺激活性。
Biomolecules. 2022 May 17;12(5):713. doi: 10.3390/biom12050713.
4
A frameshift mutation in the murine gene causes dystonia and exhibits abnormal cerebellar development and reduced eIF2α phosphorylation.小鼠基因中的一个移码突变会导致肌张力障碍,并表现出小脑发育异常和真核起始因子2α(eIF2α)磷酸化减少。
bioRxiv. 2024 Jun 4:2024.06.04.597421. doi: 10.1101/2024.06.04.597421.
5
A truncated PACT protein resulting from a frameshift mutation reported in movement disorder DYT16 triggers caspase activation and apoptosis.一种截短的 PACT 蛋白,由运动障碍 DYT16 中报道的移码突变引起,触发半胱天冬酶激活和细胞凋亡。
J Cell Biochem. 2019 Nov;120(11):19004-19018. doi: 10.1002/jcb.29223. Epub 2019 Jun 27.
6
dsRNA binding protein PACT/RAX in gene silencing, development and diseases.双链RNA结合蛋白PACT/RAX在基因沉默、发育及疾病中的作用
Front Biol (Beijing). 2014 Oct;9(5):382-388. doi: 10.1007/s11515-014-1325-z.
7
Contribution of the two dsRBM motifs to the double-stranded RNA binding and protein interactions of PACT.PACT 双链 RNA 结合和蛋白相互作用中两个 dsRBM 基序的贡献。
J Cell Biochem. 2018 Apr;119(4):3598-3607. doi: 10.1002/jcb.26561. Epub 2018 Jan 4.
8
Altered activation of protein kinase PKR and enhanced apoptosis in dystonia cells carrying a mutation in PKR activator protein PACT.蛋白激酶PKR激活改变,且携带PKR激活蛋白PACT突变的肌张力障碍细胞中的细胞凋亡增强。
J Biol Chem. 2015 Sep 11;290(37):22543-57. doi: 10.1074/jbc.M115.669408. Epub 2015 Jul 31.
9
Inhibition of the inflammatory response to stress by targeting interaction between PKR and its cellular activator PACT.通过靶向 PKR 与其细胞激活剂 PACT 之间的相互作用来抑制应激引起的炎症反应。
Sci Rep. 2017 Nov 23;7(1):16129. doi: 10.1038/s41598-017-16089-8.
10
PACT, a stress-modulated cellular activator of interferon-induced double-stranded RNA-activated protein kinase, PKR.PACT,一种应激调节的干扰素诱导双链RNA激活蛋白激酶(PKR)的细胞激活剂。
J Biol Chem. 2000 Dec 1;275(48):37993-8. doi: 10.1074/jbc.M004762200.

引用本文的文献

1
PACT prevents aberrant activation of PKR by endogenous dsRNA without sequestration.PACT可防止内源性双链RNA在无隔离的情况下异常激活PKR。
Nat Commun. 2025 Apr 8;16(1):3325. doi: 10.1038/s41467-025-58433-x.
2
Luteolin Is a Potential Immunomodulating Natural Compound against Pulpal Inflammation.木犀草素是一种潜在的牙髓炎症免疫调节天然化合物。
Biomed Res Int. 2024 Jan 25;2024:8864513. doi: 10.1155/2024/8864513. eCollection 2024.
3
PRKRA promotes pancreatic cancer progression by upregulating MMP1 transcription via the NF-κB pathway.

本文引用的文献

1
Recent Updates on Source, Biosynthesis, and Therapeutic Potential of Natural Flavonoid Luteolin: A Review.天然黄酮木犀草素的来源、生物合成及治疗潜力的最新进展:综述
Metabolites. 2022 Nov 20;12(11):1145. doi: 10.3390/metabo12111145.
2
Early-Onset Dystonia, Exacerbation With Fever, and Striatal Signal Changes: Emerging Phenotype of DYT-.早发性肌张力障碍、发热时病情加重及纹状体信号改变:DYT-的新出现表型
Neurology. 2022 Aug 2;99(5):206-207. doi: 10.1212/WNL.0000000000200858. Epub 2022 Jun 3.
3
Anti-Inflammatory and Active Biological Properties of the Plant-Derived Bioactive Compounds Luteolin and Luteolin 7-Glucoside.
PRKRA通过NF-κB途径上调MMP1转录促进胰腺癌进展。
Heliyon. 2023 Jun 10;9(6):e17194. doi: 10.1016/j.heliyon.2023.e17194. eCollection 2023 Jun.
植物源生物活性化合物木樨草素和木樨草素 7-葡萄糖苷的抗炎和活性生物学特性。
Nutrients. 2022 Mar 9;14(6):1155. doi: 10.3390/nu14061155.
4
Heterozygous Variant Causes Adolescence-Onset Generalized Dystonia Partially Responsive to DBS.杂合变异导致青少年期起病的全身性肌张力障碍,对脑深部电刺激有部分反应。
Mov Disord Clin Pract. 2021 Nov 21;9(2):268-271. doi: 10.1002/mdc3.13371. eCollection 2022 Feb.
5
Possible -Associated Stress-Related Neurological Decompensation with Combined Dystonia and Striatal Lesions.可能与压力相关的神经功能失代偿合并肌张力障碍和纹状体病变
Mov Disord Clin Pract. 2021 Dec 16;9(2):240-244. doi: 10.1002/mdc3.13384. eCollection 2022 Feb.
6
Inhibition of PKR by Viruses.病毒对蛋白激酶R的抑制作用。
Front Microbiol. 2021 Oct 25;12:757238. doi: 10.3389/fmicb.2021.757238. eCollection 2021.
7
A Recurrent EIF2AK2 Missense Variant Causes Autosomal-Dominant Isolated Dystonia.一种复发性EIF2AK2错义变异导致常染色体显性孤立性肌张力障碍。
Ann Neurol. 2021 Jun;89(6):1257-1258. doi: 10.1002/ana.26081. Epub 2021 May 4.
8
PRKRA-Related Disorders: Bilateral Striatal Degeneration in Addition to DYT16 Spectrum.与PRKRA相关的疾病:除DYT16谱系外的双侧纹状体变性
Mov Disord. 2021 Apr;36(4):1038-1040. doi: 10.1002/mds.28492. Epub 2021 Feb 19.
9
Dystonia updates: definition, nomenclature, clinical classification, and etiology.肌张力障碍更新:定义、命名、临床分类和病因。
J Neural Transm (Vienna). 2021 Apr;128(4):395-404. doi: 10.1007/s00702-021-02314-2. Epub 2021 Feb 19.
10
Role of luteolin in overcoming Parkinson's disease.木樨草素在克服帕金森病中的作用。
Biofactors. 2021 Mar;47(2):198-206. doi: 10.1002/biof.1706. Epub 2021 Jan 14.